Oncology Groups Ask HHS To Revise How Sequester’s Cuts Are Applied To Part B Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
A 2% cut is being applied first to the average sales price for drugs reimbursed by Medicare Part B, and then another 2% is taken out of the 6% add-on. The approach compounds the overall reduction to a level that far exceeds the 2% Medicare cut required by sequestration, according to the groups.